It's a common question for coffee lovers with an enlarged prostate who experience excessive nighttime urination—Could caffeine be responsible for those nightly trips to the bathroom?
Sometimes a man with benign prostatic hyperplasia (BPH) suddenly becomes unable to urinate at all--a problem that requires immediate medical attention in a hospital emergency department.
A beverage made from fermented whey improves moderately bothersome lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH), according to a small European study. The drink also appears to reduce the cell damage that promotes BPH.
Did you know that as your weight creeps up, so does the size of your prostate? Research has shown that overweight men are more likely to develop benign prostatic hyperplasia (BPH) than their normal-weight counterparts. The good news is that maintaining a healthy weight by eating right and exercising could tip the odds of having a healthy prostate in your favor.
Transurethral needle ablation (TUNA) for BPH has been available for more than a decade. Today, however, most urologists have abandoned it. Here's why the procedure is no longer recommended.
You have more frequent urges to urinate, but then you get a hesitant, weak stream or dribbling. You may have trouble getting a solid night's sleep and may dread waiting in line for the men's room or seeing the "fasten seat belt" sign illuminated in an airplane. Experiences such as these are commonly reported by older men who have an enlarged prostate, also known as benign prostatic hyperplasia (BPH). Although no one knows what causes the prostate gland to grow, there are several theories.
Men who bicycle regularly needn't worry that the activity will have adverse effects on their urinary tract or on their erectile function, according to a large multinational study in The Journal of Urology.
Surgery is the fastest, most reliable way to improve lower urinary tract symptoms related to benign prostatic hyperplasia (BPH). But compared with other treatment options, it is associated with a greater risk of long-term complications. Now that medications are available to treat BPH, fewer men are opting for surgery. However, when medical therapy fails or when symptoms are severe, surgery may be recommended.
Benign prostatic hyperplasia (BPH), commonly referred to as an enlarged prostate, is the most common prostate problem for men older than age 50. It can cause lower urinary tract symptoms such as difficulty starting urination or a weak urine stream. If the symptoms are more than mildly bothersome and interfere with a man's daily life, treatment options are available. Because other diseases can cause similar symptoms, a careful medical history, a physical examination, and laboratory tests are required to rule out other conditions. Here are tests your doctor might order to help make the diagnosis.
At age 20, the prostate is about the size of a crab apple, but by age 70, the average prostate has doubled in size. The condition, known as benign prostatic hyperplasia, or BPH, is the most common prostate problem for men older than age 50. Here's a brief look at what happens to an aging prostate—and why.
The prostate is not a component of the urinary system, but because of its proximity to the urethra it can affect urinary function.
Treatment decisions for BPH are based on the severity of symptoms as assessed by the International Prostate Symptom Score questionnaire, the extent of urinary tract damage, and the man's age and overall health.
Some reports indicate that as many as 30 percent of men who undergo surgery for benign prostatic hyperplasia (BPH) have symptoms that were caused by something other than an enlarged prostate. A medical history helps doctors identify conditions that can mimic BPH.
The American Urological Association (AUA) recently updated its guidelines on commonly used surgical procedures and minimally invasive surgical treatments. Following is the group's latest advice on which to consider—and which to avoid.
Some men who take medication for benign prostatic hyperplasia (BPH) that belongs to a class of drugs known as 5-alpha reductase inhibitors (5-ARIs) have reported developing depression and suicidal thoughts, but this risk appears to be small.